P. Chavanet

7.4k total citations
186 papers, 3.5k citations indexed

About

P. Chavanet is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, P. Chavanet has authored 186 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Infectious Diseases, 90 papers in Epidemiology and 30 papers in Pharmacology. Recurrent topics in P. Chavanet's work include Pneumonia and Respiratory Infections (39 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Antibiotic Resistance in Bacteria (24 papers). P. Chavanet is often cited by papers focused on Pneumonia and Respiratory Infections (39 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Antibiotic Resistance in Bacteria (24 papers). P. Chavanet collaborates with scholars based in France, United States and Switzerland. P. Chavanet's co-authors include H. Portier, Lionel Piroth, Michel Duong, Michèle Grappin, Marielle Buisson, Pierre‐Emmanuel Charles, Serge Aho, Denis Caillot, Frédéric Dalle and Delphine Croisier and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

P. Chavanet

178 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P. Chavanet 1.7k 1.6k 509 437 425 186 3.5k
H. Portier 1.4k 0.9× 1.2k 0.8× 519 1.0× 317 0.7× 361 0.8× 112 2.6k
Lionel Piroth 2.1k 1.2× 2.0k 1.3× 708 1.4× 1.1k 2.5× 246 0.6× 208 4.5k
Giancarlo Ceccarelli 1.5k 0.9× 956 0.6× 400 0.8× 220 0.5× 251 0.6× 238 4.3k
Mario Cruciani 2.4k 1.4× 1.9k 1.2× 264 0.5× 173 0.4× 279 0.7× 156 4.7k
Hsin‐Yun Sun 2.7k 1.6× 3.2k 2.1× 505 1.0× 1.1k 2.4× 435 1.0× 263 5.6k
Ercole Concia 1.6k 1.0× 1.7k 1.1× 135 0.3× 741 1.7× 260 0.6× 174 3.8k
Michael S. Simberkoff 2.7k 1.6× 2.6k 1.7× 757 1.5× 194 0.4× 432 1.0× 108 5.5k
María Ángeles Marcos 1.5k 0.9× 4.4k 2.8× 707 1.4× 251 0.6× 171 0.4× 180 6.4k
Amy Weintrob 1.6k 0.9× 1.6k 1.0× 696 1.4× 447 1.0× 268 0.6× 98 4.0k
Annelies Verbon 1.9k 1.2× 2.1k 1.3× 207 0.4× 113 0.3× 232 0.5× 227 5.5k

Countries citing papers authored by P. Chavanet

Since Specialization
Citations

This map shows the geographic impact of P. Chavanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chavanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chavanet more than expected).

Fields of papers citing papers by P. Chavanet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Chavanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chavanet. The network helps show where P. Chavanet may publish in the future.

Co-authorship network of co-authors of P. Chavanet

This figure shows the co-authorship network connecting the top 25 collaborators of P. Chavanet. A scholar is included among the top collaborators of P. Chavanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Chavanet. P. Chavanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chavanet, P., Isabelle Fournel, Abderrahmane Bourredjem, et al.. (2023). Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study. BMJ Open. 13(7). e073032–e073032. 1 indexed citations
2.
Blot, Mathieu, Jean‐Baptiste Bour, Jean‐Pierre Quenot, et al.. (2021). The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome (vol 18, 457, 2020). Journal of Translational Medicine. 19(1). 2–2. 1 indexed citations
3.
Maitre, Thomas, Patrice Muret, Mathieu Blot, et al.. (2019). Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice. Current HIV Research. 17(3). 190–197. 3 indexed citations
4.
Louis, Magali, Jonathan Cottenet, Arnaud Salmon‐Rousseau, et al.. (2019). Prevalence and incidence of kidney diseases leading to hospital admission in people living with HIV in France: an observational nationwide study. BMJ Open. 9(5). e029211–e029211. 6 indexed citations
5.
Dalle, Frédéric, Louise Basmaciyan, Stéphane Valot, et al.. (2018). Fatal invasive otitis with skull base osteomyelitis caused by Saksenaea vasiformis. QJM. 111(7). 499–500. 4 indexed citations
6.
Maitre, Thomas, Aurélie Chauffour, Christine Bernard, et al.. (2017). Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?. Journal of Antimicrobial Chemotherapy. 72(8). 2326–2333. 25 indexed citations
7.
Putot, Alain, Sophie Perrin, Henri Bailly, et al.. (2016). A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients. Journal of the American Medical Directors Association. 17(12). 1123–1128. 13 indexed citations
8.
Blot, Mathieu, Arnaud Salmon‐Rousseau, P. Chavanet, & Lionel Piroth. (2016). Corticosteroids in treating community-acquired pneumonia: has the time really come?. Clinical Microbiology and Infection. 23(5). 276–278. 3 indexed citations
9.
Chavanet, P.. (2013). The ZEPHyR study: A randomized comparison of linezolid and vancomycin for MRSA pneumonia. Médecine et Maladies Infectieuses. 43(11-12). 451–455. 35 indexed citations
10.
Chavanet, P.. (2012). Pneumococcus infections: Is the burden still as heavy?. Médecine et Maladies Infectieuses. 42(4). 149–153. 7 indexed citations
11.
Mahy, Sophie, et al.. (2011). Emergence of tularemia in France: paradigm of the Burgundy region. International Journal of Infectious Diseases. 15(12). e882–e883. 6 indexed citations
12.
Charles, Pierre‐Emmanuel, Pierre Tissières, Saber Davide Barbar, et al.. (2011). Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptide. Critical Care. 15(4). R181–R181. 32 indexed citations
13.
Cassier, Pierre, Sébastien Lalléchère, Serge Aho, et al.. (2010). Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case–control study in a French teaching hospital. Clinical Microbiology and Infection. 17(11). 1746–1751. 38 indexed citations
14.
Martha, B., Delphine Croisier, Annlyse Fanton, et al.. (2009). Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients. Clinical Microbiology and Infection. 16(6). 617–623. 8 indexed citations
15.
Biotti, Damien, Samuel Bidot, Sophie Mahy, et al.. (2009). Ocular Syphilis and HIV Infection. Sexually Transmitted Diseases. 37(1). 41–43. 18 indexed citations
16.
Hoen, Bruno, et al.. (2007). Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.. PubMed. 11(1). 78–84. 50 indexed citations
17.
Charles, Pierre‐Emmanuel, H. Zeller, Bernard Bonnotte, et al.. (2003). Imported West Nile Virus Infection in Europe. Emerging infectious diseases. 9(6). 750–750. 1 indexed citations
18.
Portier, H., Michèle Grappin, & P. Chavanet. (2003). Nouvelle stratégie de prise en charge des angines en France. Bulletin de l Académie Nationale de Médecine. 187(6). 1107–1116. 4 indexed citations
19.
Vittecoq, Daniel, R Roué, C Mayaud, et al.. (1987). ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS. The Lancet. 329(8533). 612–615. 28 indexed citations
20.
Chavanet, P., et al.. (1984). Valeur comparée des réactions de fixation du complément et d'immunofluorescence indirecte pour le dépistage de la fièvre Q.. 32(1). 53–55. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Portier Breakdown of academic impact, for papers by Lionel Piroth Breakdown of academic impact, for papers by Giancarlo Ceccarelli Breakdown of academic impact, for papers by Mario Cruciani Breakdown of academic impact, for papers by Hsin‐Yun Sun Breakdown of academic impact, for papers by Ercole Concia Breakdown of academic impact, for papers by Michael S. Simberkoff Breakdown of academic impact, for papers by María Ángeles Marcos Breakdown of academic impact, for papers by Amy Weintrob Breakdown of academic impact, for papers by Annelies Verbon
Rankless by CCL
2026